handshake-istock-512549722-choreograph-
Choreograph / iStockphoto.com
9 August 2017Americas

Dermira acquires licensing rights to Roche dermatitis drug

Biopharmaceutical company Dermira has acquired the licensing rights to lebrikizumab, a treatment for atopic dermatitis, from Roche.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
7 October 2016   Roche is working hard to fight cancer and lead the way in personalised medicine, while at the same time dealing with patenting, litigation and other challenges, says chief IP counsel Mike Young in an interview with LSIPR.

More on this story

Americas
7 October 2016   Roche is working hard to fight cancer and lead the way in personalised medicine, while at the same time dealing with patenting, litigation and other challenges, says chief IP counsel Mike Young in an interview with LSIPR.

More on this story

Americas
7 October 2016   Roche is working hard to fight cancer and lead the way in personalised medicine, while at the same time dealing with patenting, litigation and other challenges, says chief IP counsel Mike Young in an interview with LSIPR.